Letters to the Editor

• Clinical management indicators for the cardiovascular area. A note for the debate. Response

  José R. González-Juanatey, Alejandro Virgós Lamela, José M. García-Acuña, Beatriz Pais Iglesias

  Rev Esp Cardiol. 2021;74:202-3

• Elevated baseline renin levels as a possible cause of worse prognosis of COVID-19 in patients with heart disease

  Esther Guerrero Pérez, José Manuel Andreu Cayuelas, Marina Navarro Peñalver, Alicia Mateo Martínez

  Rev Esp Cardiol. 2021;74:203-4

• Chest pain unit: do not forget the clinical indexes

  Manuel Martínez-Sellés, Juan Sanchis, Héctor Bueno

  Rev Esp Cardiol. 2021;74:113

• Chest pain unit: do not forget the clinical indexes. Response

  Miriam Piñeiro-Portela, Jesús Peteiro-Vázquez, Alberto Bouzas-Mosquera, José Manuel Vázquez-Rodríguez

  Rev Esp Cardiol. 2021;74:113-4

• The use of antiplatelet agents for arterial thromboprophylaxis in COVID-19

  Chia Siang Kow, Syed Shahzad Hasan

  Rev Esp Cardiol. 2021;74:114-5

• A new inflammatory-microthrombotic syndrome as an explanation for thrombotic complications in patients with COVID-19

  Francisco Valga, Nicanor Vega-Díaz, Manuel Macía, José Carlos Rodríguez-Pérez

  Rev Esp Cardiol. 2021;74:115-6

• Arterial thrombotic complications in hospitalized patients with COVID-19. Response to related letters

  Juan R. Rey, José Luis Merino, Ángel M. Iniesta, Juan Caro-Codón, CARD-COVID investigators

  Rev Esp Cardiol. 2021;74:116

• Telematic cardiology consultation in the elderly. The 5M framework can help

  Pablo Díez-Villanueva, Clara Bonanad, Albert Ariza-Solé, Manuel Martínez-Sellés

  Rev Esp Cardiol. 2021;74:116-7

• Telematic cardiology consultation in the elderly. The 5M framework can help. Response

  Vivencio Barrios, Juan Cosín-Sales, Carlos Escobar

  Rev Esp Cardiol. 2021;74:118

• Typical angina, atypical angina, and atypical chest pain: is it time to change this terminology?

  Jaume Sagristà-Sauleda, José A. Barrabés

  Rev Esp Cardiol. 2021;74:118-9

• Melatonin, coronavirus, cardiovascular disease, and the geriatric emergency: let's use everything we have!

  Alberto Domínguez-Rodríguez, Russel J. Reiter, Pedro Abreu-González, Paul E. Marik

  Rev Esp Cardiol. 2020;73:1081-2

• Melatonin, coronavirus, cardiovascular disease, and the geriatric emergency: let's use everything we have! Response

  Sergio García-Blas, Pablo Díez-Villanueva, Francisco Tarazona-Santabalbina, Clara Bonanad

  Rev Esp Cardiol. 2020;73:1082

• Do we have a new drug for heart rate control in patients with permanent atrial fibrillation?

  Nuria Rivas-Gándara, Jaume Francisco-Pascual

  Rev Esp Cardiol. 2020;73:1082-3

• Do we have a new drug for heart rate control in patients with permanent atrial fibrillation? Response

  Adolfo Fontenla, Juan Tamargo Menéndez, María López Gil, Fernando Arribas

  Rev Esp Cardiol. 2020;73:1083-4

• Competing risk largely explains the drop in admissions for acute cardiovascular disease during the COVID-19 pandemic

  Luis Rodríguez-Padial, Miguel Ángel Arias

  Rev Esp Cardiol. 2020;73:1084-5

• Competing risk largely explains the drop in admissions for acute cardiovascular disease during the COVID-19 pandemic. Response

  Aida Ribera, Josepa Mauri Ferré, Rafael Romaguera

  Rev Esp Cardiol. 2020;73:1085

• Simultaneous percutaneous repair in mitral and tricuspid regurgitation: step by step

  Juan Diego Sánchez Vega, Luisa Salido Tahoces, José Luis Zamorano, Ángel Sánchez-Recalde

  Rev Esp Cardiol. 2020;73:1085-6

• Simultaneous percutaneous repair in mitral and tricuspid regurgitation: step by step. Response

  Rodrigo Estévez-Loureiro, Berenice Caneiro-Queija, José Antonio Baz, Andrés Íñiguez-Romo

  Rev Esp Cardiol. 2020;73:1086-7

• Prothrombosis in times of COVID-19

  Iñigo Pereiro Lili, Ainara Lozano Bahamonde, Nora García Ibarrondo

  Rev Esp Cardiol. 2020;73:1087-9

• New words, not always clearer

  Jordi Delás

  Rev Esp Cardiol. 2020;73:1089